2-(2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)-11-methyl-5H-benzo[d]pyrimido[4,5-f][1,3]diazepin-6(7H)-one

ID: ALA4787806

PubChem CID: 162669889

Max Phase: Preclinical

Molecular Formula: C24H27N7O2

Molecular Weight: 445.53

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)-c1c(C)cccc1NC(=O)N2

Standard InChI:  InChI=1S/C24H27N7O2/c1-15-5-4-6-18-21(15)22-19(28-24(32)27-18)14-25-23(29-22)26-17-8-7-16(13-20(17)33-3)31-11-9-30(2)10-12-31/h4-8,13-14H,9-12H2,1-3H3,(H,25,26,29)(H2,27,28,32)

Standard InChI Key:  DUDHGXRJISWWQC-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   36.6112   -2.2493    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.6101   -3.0688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.3181   -3.4778    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.3163   -1.8404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.0280   -3.0698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.0250   -2.2457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.6700   -1.7237    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.4778   -1.8989    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.8392   -2.6424    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.4870   -3.3927    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.6819   -3.5805    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.4434   -4.3701    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.0091   -4.9727    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.8164   -4.7803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.0511   -3.9910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.9827   -1.2563    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.9021   -3.4769    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.9014   -4.2941    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.1933   -4.7005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.1923   -5.5170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9002   -5.9270    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.6106   -5.5145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.6081   -4.6994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4863   -4.2906    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.7778   -4.6979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9006   -6.7441    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.1905   -7.1499    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.1890   -7.9635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8951   -8.3755    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.6044   -7.9678    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.6076   -7.1480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8924   -9.1927    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6478   -4.5566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  5  2  0
  6  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  5 11  1  0
  7  8  1  0
  8  9  1  0
 10  9  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  8 16  2  0
  2 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 19 24  1  0
 24 25  1  0
 21 26  1  0
 26 27  1  0
 26 31  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 29 32  1  0
 12 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4787806

    ---

Associated Targets(Human)

TNK2 Tclin Tyrosine kinase non-receptor protein 2 (2836 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

BaF3 (4657 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 445.53Molecular Weight (Monoisotopic): 445.2226AlogP: 3.91#Rotatable Bonds: 4
Polar Surface Area: 94.65Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 12.72CX Basic pKa: 7.84CX LogP: 3.68CX LogD: 3.11
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.56Np Likeness Score: -1.11

References

1. Li Z,Powell CE,Groendyke BJ,Gero TW,Feru F,Feutrill J,Chen B,Li B,Szabo H,Gray NS,Scott DA.  (2020)  Discovery of a series of benzopyrimidodiazepinone TNK2 inhibitors via scaffold morphing.,  30  (19): [PMID:32739400] [10.1016/j.bmcl.2020.127456]

Source